trulicity a glp 1 Lilly Launches in the US – First Ever Ready-to-Use Once-Weekly -1 Receptor Agonist Trulicity: Side Effects, Dosage, Cost,

doi: 10.1016/j.regpep.2004.08.004

GLP-1 use is transforming the weight loss landscape, with a 700% increase in use among adults without diabetes between 2019 and 2023, yet 30% of patients stop treatment within the first four weeks

On the other hand, semaglutide and tirzepatide produce dramatically more weight loss than Pendulum

In sensitivity analyses, we investigated whether recent psychiatric history, defined as any hospitalization in a psychiatric department, psychiatric consultation or dispensing of psychotropics that occurred within the year preceding the index date, altered the association between GLP-1 RA and the risk of suicide or suicide attempts